Astair/Astair Chewable Dosage & Drug Information

Indications/Uses

Prophylaxis & chronic treatment of asthma including prevention of day- & nighttime symptoms. Aspirin-sensitive asthmatic patients. Prevention of exercise-induced bronchoconstriction. Symptomatic relief of day- & nighttime seasonal (adult & childn ≥2 yr) & perennial allergic rhinitis (adult & childn ≥6 mth).

Dosage/Direction for Use

Asthma or allergic rhinitis Adult ≥15 yr One 10 mg or two 5 mg tab daily. Childn 6-14 yr One 5 mg tab daily.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity.

Special Precautions

Not for treatment of acute asthma attacks. Do not substitute abruptly for inhaled or oral corticosteroids. Monitor for neuropsychiatric events. W/drawal or dose reduction of oral corticosteroid therapy. Pregnancy & lactation. Infant <6 mth.

Adverse Reactions

Abdominal pain, headache, diarrhea, hyperkinesia, asthma, eczematous dermatitis, rash, somnolence.

View ADR Reporting Link

Drug Interactions

Decreased plasma AUC w/ phenobarb. Increased systemic exposure w/ gemfibrozil.

MIMS Class

Antiasthmatic & COPD Preparations

ATC Classification

R03DC03 - montelukast ; Belongs to the class of leukotriene receptor antagonists. Used in the systemic treatment of obstructive airway diseases.

Thai FDA Category

D

Presentation/Packing

Form

Astair Chewable tab 5 mg

Packing/Price

4 × 7's

Form

Astair FC tab 10 mg

Packing/Price

4 × 7's

Astair/Astair Chewable

montelukast

Manufacturer:

Sriprasit Pharma

Distributor:

SPS Medical

Marketer:

SPS Medical